Fremanezumab Shows Dual Efficacy in Treating Migraine and Comorbid Major Depressive Disorder: JAMA Dr Riya Dave7 May 2025 9:00 PM ISTResearchers have found in a new study that Fremanezumab proved effective in reducing symptoms of both migraine and comorbid major depressive disorder...
Medical Bulletin 07/ May/ 2025 Dr. Bhumika Maikhuri7 May 2025 3:00 PM ISTHere are the top medical news for the day:Simple Habits, Big Impact: Study Reveals Keys to Mental WellnessSimple, everyday behaviours such as chatting...
Can Migraine Medication Reduce Depression Symptoms Too? Study Finds Dr. Bhumika Maikhuri7 May 2025 8:15 AM ISTA migraine medication has been found to significantly reduce symptoms of both migraine and depression, marking the first clinical trial to demonstrate...
New ACP guideline recommends combination therapy for acute episodic migraines Dr. Kamal Kant Kohli6 May 2025 9:15 PM ISTThe American College of Physicians (ACP) has developed new recommendations for treatment of acute episodic migraines in nonpregnant adults in...
FDA Approves Atzumi Nasal Powder for Acute Migraine Treatment Dr. Kamal Kant Kohli3 May 2025 8:15 AM ISTThe US Food and Drug Administration (FDA) has approved Atzumi, a 5.2 mg dihydroergotamine (DHE) nasal powder, for the acute treatment of migraine...
Migraine with aura associated with young-onset cryptogenic ischemic stroke in women: Study Jacinthlyn Sylvia27 April 2025 10:45 PM ISTA new study published in the journal of Stroke showed that the most common cause of young-onset cryptogenic ischemic stroke (CIS), particularly in...
Poor oral health linked with body pain and migraines in women in new study Dr. Kamal Kant Kohli25 April 2025 8:45 PM ISTNew research from the University of Sydney has revealed poor oral health is significantly associated with higher instances of migraines, abdominal and...
Zonisamide another option for reducing migraine attacks in children, suggests study Dr. Kamal Kant Kohli5 March 2025 8:45 PM ISTFor children and teens living with migraine, there may be a new preventive treatment, according to a preliminary study released today, February 26,...
Strong Link Between Headache Diagnoses and Suicide Risk Highlights Need for Behavioral Health Support: JAMA Dr Riya Dave4 Feb 2025 8:45 PM ISTResearchers in a new study have found that patients diagnosed with headache disorders are at a significantly higher risk of attempted and completed...
FDA Approves Symbravo for Acute Migraine Treatment Dr. Kamal Kant Kohli2 Feb 2025 8:30 PM ISTThe US Food and Drug Administration FDA has approved Symbravo, an oral combination of meloxicam and rizatriptan, for the treatment of acute migraine...
Propranolol May reduce ischemic stroke risk alongside preventing Migraine in women: Study Dr. Kamal Kant Kohli31 Jan 2025 8:30 PM ISTFor patients with migraine, the clinical benefits of propranolol, a beta-blocker medication, may extend beyond just migraine prophylaxis, according to...
New Frontiers in Migraine Management: Expert Insights from Dr Peter Goadsby, Neurologist Dr. Nandita Mohan24 Jan 2025 8:00 AM ISTIn conversation with Dr Peter Goadsby, Director of NIHR Clinical Research Facility and Professor of Neurology at King's College, London. Dr Peter...
